Antiviral activity of 3,4'-dihydroxyflavone on influenza a virus

Journal of Microbiology

Volumn 52, Issue 6, 2014, Pages 521-526

  Hossain, Mohammed Kawser ^a   Choi, Hye Yeon ^a   Hwang, Jae Seon ^b   Dayem, Ahmed Abdal ^a   Kim, Jung Hyun ^a   Kim, Young Bong ^a   Poo, Haryoung ^b   Cho, Ssang Goo ^a  

^a Konkuk University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

3,4 dihydroxyflavone; 3 hydroxyl group flavonoids; flavonoid; influenza virus

Indexed keywords

3,4'-DIHYDROXYFLAVONE; ANTIVIRUS AGENT; FLAVONE DERIVATIVE;

ANIMAL; CELL LINE; DOG; DRUG EFFECTS; HUMAN; INFLUENZA VIRUS A; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; FLAVONES; HUMANS; INFLUENZA A VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84901606451     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-014-4212-z     Document Type: Article

References (24)

1. Bouvier N. M., Lowen A. C., and Palese P. 2008. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J. Virol. 82, 10052-10058.
2. Carr J., Ives J., Kelly L., Lambkin R., Oxford J., Mendel D., Tai L., and Roberts N. 2002. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Res. 54, 79-88.
3. Cerda B., Llorach R., Ceron J. J., Espin J. C., and Tomas-Barberan F. A. 2003. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur. J. Nutr. 42, 18-28.
4. Gil M. I., Tomas-Barberan F. A., Hess-Pierce B., Holcroft D. M., and Kader A. A. 2000. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48, 4581-4589.
5. Havsteen B. H. 2002. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96, 67-202.
6. Hayden F. G. 2006. Respiratory viral threats. Curr. Opin. Infect. Dis. 19, 169-178.
7. Hurt A. C., Ernest J., Deng Y. M., Iannello P., Besselaar T. G., Birch C., Buchy P., Chittaganpitch M., Chiu S. C., Dwyer D., andet al. 2009. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res. 83, 90-93.
8. Imanishi N., Tuji Y., Katada Y., Maruhashi M., Konosu S., Mantani N., Terasawa K., and Ochiai H. 2002. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol. Immunol. 46, 491-494.
9. Kim B. W., Lee E. R., Min H. M., Jeong H. S., Ahn J. Y., Kim J. H., Choi H. Y., Choi H., Kim E. Y., Park S. P., andet al. 2008. Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition. Cancer Biol. Ther. 7, 1080-1089.
10. Kim J. H., Song M., Kang G. H., Lee E. R., Choi H. Y., Lee C., Kim Y., Koo B. N., and Cho S. G. 2012. Combined treatment of 3- hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate-resistant leukemia cells. Leu. Res. 36, 1157-1164.
11. Lee E. R., Kang G. H., and Cho S. G. 2007a. Effect of flavonoids on human health: old subjects but new challenges. Recent Pat. Biotechnol. 1, 139-150.
12. Lee E. R., Kang Y. J., Choi H. Y., Kang G. H., Kim J. H., Kim B. W., Han Y. S., Nah S. Y., Paik H. D., Park Y. S., andet al. 2007b. Induction of apoptotic cell death by synthetic naringenin derivatives in human lung epithelial carcinoma A549 cells. Biol. Pharm. Bull. 30, 2394-2398.
13. Lee E. R., Kim J. H., Choi H. Y., Jeon K., and Cho S. G. 2011a. Cytoprotective effect of eriodictyol in UV-irradiated keratinocytes via phosphatase-dependent modulation of both the p38 MAPK and Akt signaling pathways. Cell. Physiol. Biochem. 27, 513-524.
14. Lee K. S., Kim E. Y., Jeon K., Cho S. G., Han Y. J., Yang B. C., Lee S. S., Ko M. S., Riu K. J., Lee H. T., andet al. 2011b. 3, 4-Dihydroxyflavone acts as an antioxidant and antiapoptotic agent to support bovine embryo development in vitro. J. Reprod. Dev. 57, 127-134.
15. Lee E. R., Kim J. H., Kang Y. J., and Cho S. G. 2007c. The antiapoptotic and anti-oxidant effect of eriodictyol on UV-induced apoptosis in keratinocytes. Biol. Pharm. Bull. 30, 32-37.
16. Liu A. L., Liu B., Qin H. L., Lee S. M., Wang Y. T., and Du G. H. 2008. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med. 74, 847-851.
17. Marjuki H., Wernery U., Yen H. L., Franks J., Seiler P., Walker D., Krauss S., and Webster R. G. 2009. Isolation of highly pathogenic avian influenza H5N1 virus from Saker falcons (Falco cherrug) in the Middle East. Adv. Virol. 2009, 1.
18. Middleton E., Jr. 1998. Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol. 439, 175-182.
19. Neumann G., Fujii K., Kino Y., and Kawaoka Y. 2005. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc. Natl. Acad. Sci. USA102, 16825-16829.
20. Palese P. 2004. Influenza: old and new threats. Nat. Med. 10, S82-87.
21. Roberts N. A. 2001. Anti-influenza drugs and neuraminidase inhibitors. Prog. Drug Res. Spec No, 35-77.
22. Smee D. F., Hurst B. L., Wong M. H., Bailey K. W., Tarbet E. B., Morrey J. D., and Furuta Y. 2010. Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice. Antimicrob. Agents Chemother. 54, 126-133.
23. Song J. M., Lee K. H., and Seong B. L. 2005. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 68, 66-74.
24. Williamson G. and Manach C. 2005. Bioavailability and bioefficacy of polyphenols in humans. Am. J. Clin. Nutr. 81, 243S-255S.